Abstract

Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising way for treating demyelinating diseases. However, generation of scalable and autologous sources of OPCs has proven difficult. We previously established a chemical condition M9 that could specifically initiate neural program in mouse embryonic fibroblasts. Here we found that M9 could induce the formation of colonies that undergo mesenchymal-to-epithelial transition at the early stage of reprogramming. These colonies may represent unstable and neural lineage-restricted intermediates that have not established a neural stem cell identity. By modulating the culture signaling recapitulating the principle of OPC development, these intermediate cells could be reprogrammed towards OPC fate. The chemical-induced OPC-like cells (ciOPLCs) resemble primary neural stem cell-derived OPCs in terms of their morphology, gene expression, and the ability of self-renewal. Upon differentiation, ciOPLCs could produce functional oligodendrocytes and myelinate the neuron axons in vitro, validating their OPC identity molecularly and functionally. Therefore, our study provides a non-integrating approach to OPC reprogramming that may ultimately provide an avenue to patient-specific cell-based or in situ regenerative therapy.

Highlights

  • Demyelinating diseases, such as multiple sclerosis, are among the most disabling and costly neurological disorders, which affect millions of people worldwide

  • Our recent study established a chemical condition M9, containing CHIR99021, LDN193189, A83-01, Hh-Ag1.5, retinoic acid (RA), SMER28, RG108, Parnate, and basic fibroblast growth factor, that enables neural reprogramming in mouse embryonic fibroblasts (MEFs) (Zhang et al, 2016)

  • In this study, we show that transiently treating MEFs with M9, followed by rationally modulating culture signaling recapitulating oligodendrocyte progenitor cells (OPCs) development, is able to reprogram MEFs into chemical-induced OPC-like cells (ciOPLCs)

Read more

Summary

Introduction

Demyelinating diseases, such as multiple sclerosis, are among the most disabling and costly neurological disorders, which affect millions of people worldwide. Demyelinating diseases are characterized by the loss or dysfunction of myelin, a Received July 15, 2018.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call